Canbi  Pharma  Teknoloġiku  Limited
540737-29-9 tofacitinib citrate

540737-29-9 tofacitinib citrate

CAS: 540737-29-9
MF: C16H20N6O.C6H8O7
MW: 504.497
Einecs: 638-826-4
MDL No.:MFCD11616529

Ibgħat l-inkjesta
Deskrizzjoni

Proprjetajiet
Punt tat-tidwib: 201 grad (dekomp)
Temp tal-Ħażna. Temp tal-kamra
Solubilità DMSO: Soluble5mg / mL (Soluzzjoni ċara; imsaħħna)
Dehra bajda għal trab beige

 

Applikazzjoni:

Tofacitinib (cp -690550) Citrate huwa inibitur ġdid ta 'JAK3 b'IC50 ta' 1 nm, u s-selettività tiegħu lejn JAK2 u JAK1 hija 20 sa 100 darba inqas.

 

Sinonimi:

Tofacitinib citrate

540737-29-9

Tasocitinib Citrate

Xeljanz

Tofacitinib (cp -690550 citrate

Tofacitinib (ċitrat)

Monokitrat tasocitinib

Tofacitinib monocitrate

3- ((3r, 4r) -4- methyl -3- (methyl (7h-pyrrolo [2, {3- d] pyrimidin -4- yl) amino) piperidin -1- yl) {11}} oxopropanen 2- hydroxypropane -1, 2, 3- tricarboxylate

1- piperidinepropanenitrile, 4- metil -3- (metil -7} h-pyrrolo (2, {{{3-} d) pyrimidin -4- ylamino) - beta-oxo-, (3r, 4r) 2- hydroxy -1, 2, 3- propanetricarboxylate (1: 1)

2- hydroxypropane -1, 2, 3- aċidu tricarboxylic; 3- [(3r, 4r) -4- methyl -3- [metil ({7h-pyrrolo [2, {3- d] pyr iMidin -4- yl}) amino] piperidin -1- yl] -3- oxopropanenitrile

2- hydroxypropane -1, 2, 3- tricarboxylic aċidu; 3- [(3r, 4r) -4- methyl -3- [metil (7h-pyrrolo [2, {3- d] pyrimidin -4- yl) piperidin -1- yl] {{15

3- ((3r, 4r) -4- methyl -3- (metil (7h-pyrrolo (2, {3- d) pyrimidin -4- yl) amino) piper Idin -1- yl) -3- oxo-propanenitrile 2- hydroxypropan -1, 2, {{3-}} tricarboxylate (1: 1)

3- ((3r, 4r) -4- methyl -3- (methyl (7h-pyrrolo (2, {3- d) pyrimidin -4- yl) amino) piperidin -1- yl) {11}} oxopropanenitrile 2- hydroxypropane -1, 2, 3- tricarboxylate

3- {(3r, 4r) -4- methyl -3- [metil (7h-pyrrolo [2, {3- d] pyrimidin -4- yl) piperidin -1- yl} {11 2- hydroxypropane -1, 2, 3- tricarboxylate

3- {(3r, 4r) -4- metil -3- [metil- (7h-pyrrolo [2, {3- d] pyri midin -4- yl) -amino] -piperidin -1- yl} -3- oxo-propionitrile melħ taċ-ċitrat

3- {(3r, 4r) -4- metil -3- [metil- (7h-pyrrolo [2, {3- d] pyri midin -4- yl} -amino] -piperidin -1- yl) -3- oxo-propionitrile melħ taċ-ċitrat

XelJanz (TN)

Xeljanzxr

Melħ ta 'aċidu ċitriku tasocitinib

Tofacitinib Citrate [Jan]

C16H20N6O.C6H8O7

Syikufdoyjfgbq-ilafaasesa-n

Tofacitinib (ċitrat) (standard)

Tofacitinib monocitrate [mi]

Tofacitinib citrate [WHO-DD]

AKOS022178222

Tofacitinib citrate, >=98% (hplc)

Tofacitinib Citrate [Oranġjo Ktieb]

CP 690550 Citrate (Tofacitinib Citrate)

Tofacitinib citrate (cp -690550 citrate)

(3r, 4r) -4- methyl -3- (metil -7 h-pyrro lo [2, 3- d] pyrimidin -4-}} ylamino) -beta-oxo {{11} piperidinePro panenitrile ċitert

(3r, 4r) -4- methyl -3- (methyl -7 h-pyrrolo [2, 3- d] pyrimidin -4-}} ylamino) -beta-oxo -1- Piperidine Propanenitrile 2- hydroxy -1, 2, 3- propanetricarboxylate

1- piperidinepropanenitrile, 4- metil -3- (metil {-7} h-pyrrolo (2, {{3-} d) pyrimidin -4- ylamino) -. Beta.-oxo-, (3r, 4R) 2- hydroxy -1, 2, 3- Propanetricarboxylate

 

It-tags Popolari: 540737-29-9 Tofacitinib Citrate, iċ-Ċina 540737-29-9 Tofacitinib Citrate Manifatturi, Fornituri

Inquiry
goTop

(0/10)

clearall